The company has established a quality management system (CNAS/ILAC-MRA certification) that conforms to international standards, and has GLP qualifications from China's NMPA, US FDA, Japan PMDA, Korea's MFDS and the OECD, as well as international AAALAC (animal welfare) certification. The evaluation data meets global drug registration requirements. It can provide customers with one-stop services for non-clinical pharmacological toxicology research and evaluation, especially non-clinical safety evaluation, clinical trials and pharmacovigilance; it can also provide services such as evaluation of veterinary drugs, pesticides and medical devices. The company focuses on the purpose of safety evaluation and monitoring throughout the life cycle of drugs, with the vision of “ensuring the safety of patient medication use and caring for human health”, and has established a unique high-value-added industrial chain of non-clinical drug research services, clinical trials and related services, breeding and sales of high-quality experimental models, and customized services for gene editing experimental models.